Mutation M157R of keratin 9 in a Chinese family with epidermolytic palmoplantar keratoderma

Mutation M157R of keratin 9 in a Chinese family with epidermolytic palmoplantar keratoderma
复制标题

DOI:
10.1111/j.1365-4632.2008.03441.x
复制
发表时间:
2008-06
影响因子:
3.6
通讯作者:
Jing-jun Zhao;Zheng-Hua Zhang;Z. Niu;L. Xiang;X. Ye;Wei Huang;Zhi-zhong Zheng
Jing-jun Zhao;Zheng-Hua Zhang;Z. Niu;L. Xiang;X. Ye;Wei Huang;Zhi-zhong Zheng
中科院分区:
医学4区
文献类型:
--
作者:
Jing-jun Zhao;Zheng-Hua Zhang;Z. Niu;L. Xiang;X. Ye;Wei Huang;Zhi-zhong Zheng

文献摘要

被引文献

相似文献

副肿瘤性天疱疮英国皮肤病学杂志2005; 153:558-564。3 Sahadevan K,Banerjee A,Wight R.颈部淋巴结滤泡树突状细胞肉瘤1例报告并文献复习。耳鼻咽喉杂志2004; 83:848-849. 4陈俊健、曾伟英、吴俊志。滤泡树突状细胞瘤和血管肿瘤合并透明血管Castleman病美国外科病理学杂志1994; 18:517-525。5 Chan AC,Chan KW,Chan JK,et al .滤泡树突状细胞肉瘤在鼻咽透明血管型Castleman病中的发展:通过连续活检追踪其演变历史学2001; 38:510-518. 6王立,卜东,杨勇,等.副肿瘤性天疱疮中Castleman肿瘤和自身抗体的产生。柳叶刀2004; 363:525-531。7 Barnadas M,Roe E,Brunet S,et al.利妥昔单抗治疗副肿瘤性天疱疮:病例报告和文献回顾。欧洲皮肤性病学会杂志2006; 20:69-74。8 Rossum MM,Verhaegen NT,Jonkman MF,et al.滤泡性非霍奇金淋巴瘤伴难治性副肿瘤性天疱疮:病例报告及新型治疗方法综述。勒克淋巴瘤2004; 45:2327-2332。9 El Tal AK,Posner MR,Spigelman Z,et al.利妥昔单抗:一种用于治疗寻常型天疱疮的CD 20单克隆抗体。美国皮肤病学会杂志2006; 55:449- 459。10康明斯DL,Mimouni D,Tzu J等.在缺乏可检测抗体的情况下的苔藓样副肿瘤性天疱疮。美国皮肤病学会杂志2007; 56:53-159。
with paraneoplastic pemphigus. Br J Dermatol 2005; 153 : 558–564. 3 Sahadevan K, Banerjee A, Wight R. Follicular dendritic cell sarcoma of a cervical lymph node: case report and review of the literature. Ear Nose Throat J 2004; 83 : 848–849. 4 Chan JK, Tsang WY, Ng CS. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline vascular Castleman’s disease. Am J Surg Pathol 1994; 18 : 517–525. 5 Chan AC, Chan KW, Chan JK, et al . Development of follicular dendritic cell sarcoma in hyaline–vascular Castleman’s disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology 2001; 38: 510–518. 6 Wang L, Bu D, Yang Y, et al. Castleman’s tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 2004; 363: 525–531. 7 Barnadas M, Roe E, Brunet S, et al. Therapy of paraneoplastic pemphigus with rituximab: a case report and review of the literature. J Eur Acad Dermatol Venereol 2006; 20: 69–74. 8 Rossum MM, Verhaegen NT, Jonkman MF, et al. Follicular non-Hodgkin’s lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities. Leuk Lymphoma 2004; 45: 2327–2332. 9 El Tal AK, Posner MR, Spigelman Z, et al. Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2006; 55: 449– 459. 10 Cummins DL, Mimouni D, Tzu J, et al. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol 2007; 56: 53–159.